Download FREE Report Sample
Download Free sampleRabies vaccine is a vaccine to prevent the occurrence of rabies.The vaccine is very good at preventing wound infection.It can be divided into two types: one is post-exposure (bite, scratch) prevention, and the other is pre-exposure (no bite, scratch) prevention.
Vaccin Antirabic Market contains market size and forecasts of Vaccin Antirabic in global, including the following market information:
Global Vaccin Antirabic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vaccin Antirabic Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Vaccin Antirabic companies in 2021 (%)
The global Vaccin Antirabic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gopher Kidney Cell Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vaccin Antirabic include GSK, Sanofi, Chengda, Yisheng, Merck, VACN, Changsheng, BCHT and Hissen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Vaccin Antirabic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccin Antirabic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vaccin Antirabic Market Segment Percentages, by Type, 2021 (%)
Gopher Kidney Cell Vaccine
Freeze-Dried Vero Cell Vaccine
Common Vero Cell Vaccines
Human Diploid Vaccine
Global Vaccin Antirabic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vaccin Antirabic Market Segment Percentages, by Application, 2021 (%)
Pre-exposure Prophylaxis
After Exposure Prophylaxis
Additional Doses
Global Vaccin Antirabic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vaccin Antirabic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaccin Antirabic revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vaccin Antirabic revenues share in global market, 2021 (%)
Key companies Vaccin Antirabic sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Vaccin Antirabic sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Sanofi
Chengda
Yisheng
Merck
VACN
Changsheng
BCHT
Hissen
Zhongke Biological
Ningbo Rongan Biological Pharmaceutical
Guangzhou Nuocheng Biological
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
